MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2

Molecular and Cellular Biochemistry

Volumn 406, Issue 1-2, 2015, Pages 21-30

  Chen, Huajiang ^a   Wang, Jianxi ^a   Hu, Bo ^a   Wu, Xiaodong ^a   Chen, Yu ^a   Li, Renhu ^a   Yuan, Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; Cartilage endplate chondrocyte; Fas; miR 34a

Indexed keywords

FAS ANTIGEN; MICRORNA 34A; PROTEIN BCL 2; BCL2 PROTEIN, HUMAN; MICRORNA; MIRN34 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; APOPTOSIS; ARTICLE; BIOINFORMATICS; CARTILAGE CELL; CARTILAGE ENDPLATE CHONDROCYTE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERVERTEBRAL DISK DEGENERATION; MALE; MIDDLE AGED; PROTEIN EXPRESSION; UPREGULATION; BINDING SITE; CARTILAGE; CELL CULTURE; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE;

AGED; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CARTILAGE; CELLS, CULTURED; CHONDROCYTES; FEMALE; HUMANS; INTERVERTEBRAL DISC DEGENERATION; MALE; MICRORNAS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE;

EID: 84945892999     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2420-4     Document Type: Article

References (50)

1. Luoma K, Riihimaki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A (2000) Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976) 25(4):487–492
2. Maniadakis N, Gray A (2000) The economic burden of back pain in the UK. Pain 84(1):95–103
3. Raj PP (2008) Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Pract 8(1):18–44. doi:10.1111/j.1533-2500.2007.00171.x
4. Andersson GB (1999) Epidemiological features of chronic low-back pain. Lancet 354(9178):581–585. doi:10.1016/S0140-6736(99)01312-4
5. Waddell G (1996) Low back pain: a twentieth century health care enigma. Spine (Phila Pa 1976) 21(24):2820–2825
6. Rolander SD, Blair WE (1975) Deformation and fracture of the lumbar vertebral end plate. Orthop Clin North Am 6(1):75–81
7. Urban JP, Holm S, Maroudas A, Nachemson A (1977) Nutrition of the intervertebral disk. An in vivo study of solute transport. Clin Orthop Relat Res 129:101–114
8. Oegema TR Jr, Johnson SL, Aguiar DJ, Ogilvie JW (2000) Fibronectin and its fragments increase with degeneration in the human intervertebral disc. Spine (Phila Pa 1976) 25(21):2742–2747
9. Loeser RF (2002) Integrins and cell signaling in chondrocytes. Biorheology 39(1–2):119–124
10. Kuhn K, D’Lima DD, Hashimoto S, Lotz M (2004) Cell death in cartilage. Osteoarthritis Cartilage 12(1):1–16
11. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F (1998) Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 41(2):284–289. doi:10.1002/1529-0131(199802)41:2<284:AID-ART12>3.0.CO;2-T
12. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3(6):614–620
13. Kane DJ, Ord T, Anton R, Bredesen DE (1995) Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res 40(2):269–275. doi:10.1002/jnr.490400216
14. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75(2):241–251
15. Feng L, Precht P, Balakir R, Horton WE Jr (1998) Evidence of a direct role for Bcl-2 in the regulation of articular chondrocyte apoptosis under the conditions of serum withdrawal and retinoic acid treatment. J Cell Biochem 71(2):302–309
16. Rabinovitch A, Suarez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt GS, Rajotte RV (1999) Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48(6):1223–1229
17. Jovanovic M, Hengartner MO (2006) miRNAs and apoptosis: RNAs to die for. Oncogene 25(46):6176–6187. doi:10.1038/sj.onc.1209912
18. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
19. Sonkoly E, Stahle M, Pivarcsi A (2008) MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18(2):131–140. doi:10.1016/j.semcancer.2008.01.005
20. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455(7209):58–63. doi:10.1038/nature07228
21. Abouheif MM, Nakasa T, Shibuya H, Niimoto T, Kongcharoensombat W, Ochi M (2010) Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. Rheumatology 49(11):2054–2060. doi:10.1093/rheumatology/keq247
22. Yang F, Li QJ, Gong ZB, Zhou L, You N, Wang S, Li XL, Li JJ, An JZ, Wang DS, He Y, Dou KF (2013) MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment. Technol Cancer Res Treat. doi:10.7785/tcrt.2012.500364
23. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26(5):745–752. doi:10.1016/j.molcel.2007.05.010
24. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ (2007) A microRNA component of the p53 tumour suppressor network. Nature 447(7148):1130–1134. doi:10.1038/nature05939
25. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26(5):731–743. doi:10.1016/j.molcel.2007.05.017
26. Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Proto-Siqueira R, Silva-Jr WA, Falcao RP, Zago MA (2007) miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 40(11):1435–1440
27. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104(39):15472–15477. doi:10.1073/pnas.0707351104
28. Chi L, Ke Y, Luo C, Gozal D, Liu R (2007) Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 144(3):991–1003. doi:10.1016/j.neuroscience.2006.09.064
29. Aladin DM, Cheung KM, Chan D, Yee AF, Jim JJ, Luk KD, Lu WW (2007) Expression of the Trp2 allele of COL9A2 is associated with alterations in the mechanical properties of human intervertebral discs. Spine (Phila Pa 1976) 32(25):2820–2826. doi:10.1097/BRS.0b013e31815b75c5
30. Solovieva S, Lohiniva J, Leino-Arjas P, Raininko R, Luoma K, Ala-Kokko L, Riihimaki H (2006) Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. Eur Spine J 15(5):613–619. doi:10.1007/s00586-005-0988-1
31. Stokes IA, Iatridis JC (2004) Mechanical conditions that accelerate intervertebral disc degeneration: overload versus immobilization. Spine (Phila Pa 1976) 29(23):2724–2732
32. Guehring T, Omlor GW, Lorenz H, Bertram H, Steck E, Richter W, Carstens C, Kroeber M (2005) Stimulation of gene expression and loss of anular architecture caused by experimental disc degeneration—an in vivo animal study. Spine (Phila Pa 1976) 30(22):2510–2515
33. Murata Y, Olmarker K, Larsson K, Takahashi K, Rydevik B (2006) Production of tumor necrosis factor-alpha from porcine nucleus pulposus cells at various time points in cell culture under conditions of nutritional deficiency. Cytokine 34(3–4):206–211. doi:10.1016/j.cyto.2006.05.002
34. Zhao CQ, Liu D, Li H, Jiang LS, Dai LY (2007) Interleukin-1beta enhances the effect of serum deprivation on rat annular cell apoptosis. Apoptosis Int J Program Cell Death 12(12):2155–2161. doi:10.1007/s10495-007-0137-x
35. Phillips FM, Reuben J, Wetzel FT (2002) Intervertebral disc degeneration adjacent to a lumbar fusion. An experimental rabbit model. J Bone Joint Surg Br 84(2):289–294
36. Sakai D (2008) Future perspectives of cell-based therapy for intervertebral disc disease. Eur Spine J 17(Suppl 4):452–458. doi:10.1007/s00586-008-0743-5
37. Roberts S, Johnson WE (1999) Analysis of aging and degeneration of the human intervertebral disc. Spine (Phila Pa 1976) 24(5):500–501
38. Gruber HE, Norton HJ, Hanley EN Jr (2000) Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. Spine (Phila Pa 1976) 25(17):2153–2157
39. Grunhagen T, Shirazi-Adl A, Fairbank JC, Urban JP (2011) Intervertebral disk nutrition: a review of factors influencing concentrations of nutrients and metabolites. Orthop Clin North Am 42(4): 465–477, vii. doi: 10.1016/j.ocl.2011.07.010
40. Ariga K, Yonenobu K, Nakase T, Hosono N, Okuda S, Meng W, Tamura Y, Yoshikawa H (2003) Mechanical stress-induced apoptosis of endplate chondrocytes in organ-cultured mouse intervertebral discs: an ex vivo study. Spine (Phila Pa 1976) 28(14):1528–1533
41. Hutton WC, Ganey TM, Elmer WA, Kozlowska E, Ugbo JL, Doh ES, Whitesides TE Jr (2000) Does long-term compressive loading on the intervertebral disc cause degeneration? Spine (Phila Pa 1976) 25(23):2993–3004
42. Ariga K, Miyamoto S, Nakase T, Okuda S, Meng W, Yonenobu K, Yoshikawa H (2001) The relationship between apoptosis of endplate chondrocytes and aging and degeneration of the intervertebral disc. Spine (Phila Pa 1976) 26(22):2414–2420
43. Takahashi I, Onodera K, Sasano Y, Mizoguchi I, Bae JW, Mitani H, Kagayama M, Mitani H (2003) Effect of stretching on gene expression of beta1 integrin and focal adhesion kinase and on chondrogenesis through cell-extracellular matrix interactions. Eur J Cell Biol 82(4):182–192
44. Ikeda T, Kamekura S, Mabuchi A, Kou I, Seki S, Takato T, Nakamura K, Kawaguchi H, Ikegawa S, Chung UI (2004) The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50(11):3561–3573. doi:10.1002/art.20611
45. Van Wynsberghe PM, Chan SP, Slack FJ, Pasquinelli AE (2011) Analysis of microRNA expression and function. Methods Cell Biol 106:219–252. doi:10.1016/B978-0-12-544172-8.00008-6
46. Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2(3):243–247
47. Wilda M, Fuchs U, Wossmann W, Borkhardt A (2002) Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 21(37):5716–5724. doi:10.1038/sj.onc.1205653
48. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9(3):347–351
49. Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, Waltemathe M, Gosling T, Flemming P, Malek NP, Trautwein C, Manns MP, Kuhnel F, Kubicka S (2003) Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A 100(13):7797–7802
50. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452(7189):896–899. doi:10.1038/nature06783